Clinical trial

Intraoperative Imaging of Breast Cancer With Indocyanine Green

NCT01796041

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Indocyanine Green Normalized identity: indocyanine greenView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Intraoperative Imaging of Breast Cancer With Indocyanine Green

Design: INTERVENTIONAL · Status: COMPLETED · Phase: EARLY_PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-07-01

PhaseEARLY_PHASE1

Conditions

Invasive Ductal Carcinomaverified · MONDO: invasive ductal breast carcinoma

Invasive Lobular Carcinomaverified · MONDO: invasive lobular breast carcinoma

Ductal Carcinomaunresolved

Interventions

Indocyanine GreenDRUG · verified · RxNorm: indocyanine green

Sponsors & collaborators

Abramson Cancer Center at Penn Medicinelead sponsor

Mapped research locations

PhiladelphiaPennsylvania, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01796041 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.